"Plaque, Amyloid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.
Descriptor ID |
D058225
|
MeSH Number(s) |
C23.300.821
|
Concept/Terms |
Plaque, Amyloid- Plaque, Amyloid
- Amyloid Plaque
- Amyloid Plaques
- Plaques, Amyloid
- Amyloid Deposits
- Amyloid Deposit
- Deposit, Amyloid
- Deposits, Amyloid
Senile Plaques- Senile Plaques
- Plaque, Senile
- Plaques, Senile
- Senile Plaque
- Neuritic Plaques
- Neuritic Plaque
- Plaque, Neuritic
- Plaques, Neuritic
|
Below are MeSH descriptors whose meaning is more general than "Plaque, Amyloid".
Below are MeSH descriptors whose meaning is more specific than "Plaque, Amyloid".
This graph shows the total number of publications written about "Plaque, Amyloid" by people in this website by year, and whether "Plaque, Amyloid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2006 | 2 | 0 | 2 |
2007 | 0 | 2 | 2 |
2009 | 1 | 2 | 3 |
2010 | 0 | 1 | 1 |
2011 | 3 | 0 | 3 |
2012 | 0 | 3 | 3 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 2 | 1 | 3 |
2016 | 2 | 0 | 2 |
2017 | 0 | 2 | 2 |
2018 | 1 | 1 | 2 |
2019 | 1 | 1 | 2 |
2020 | 1 | 2 | 3 |
2021 | 1 | 0 | 1 |
2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plaque, Amyloid" by people in Profiles.
-
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease. Alzheimers Res Ther. 2022 11 29; 14(1):178.
-
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials. JAMA Neurol. 2022 11 01; 79(11):1113-1121.
-
Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022 07; 144(1):27-44.
-
Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid ? plaques. Immunity. 2022 05 10; 55(5):879-894.e6.
-
Combinatorial model of amyloid ? and tau reveals synergy between amyloid deposits and tangle formation. Neuropathol Appl Neurobiol. 2022 02; 48(2):e12779.
-
Gene therapy using A? variants for amyloid reduction. Mol Ther. 2021 07 07; 29(7):2294-2307.
-
Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol. 2021 01 20; 80(2):102-111.
-
Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau. Mol Psychiatry. 2021 10; 26(10):5912-5924.
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
-
Early Mitochondrial Fragmentation and Dysfunction in a Drosophila Model for Alzheimer's Disease. Mol Neurobiol. 2021 Jan; 58(1):143-155.